Patents Assigned to Femta Pharmaceuticals, Inc.
  • Humanized anti-IL-6 antibodies
    Patent number: 8173398
    Abstract: The present invention relates to novel chimeric, humanized or CDR-grafted anti-IL-6 antibodies, including isolated nucleic acids that encode at least one such anti-IL-6 antibody, vectors, host cells, transgenic animals or plants, and methods of making and using thereof, including therapeutic compositions, methods and devices.
    Type: Grant
    Filed: September 23, 2011
    Date of Patent: May 8, 2012
    Assignee: Femta Pharmaceuticals, Inc.
    Inventors: Gerhard Frey, Hwai Wen Chang, Jay Short
  • HUMANIZED ANTI-IL-6 ANTIBODIES
    Publication number: 20120006716
    Abstract: The present invention relates to novel chimeric, humanized or CDR-grafted anti-IL-6 antibodies, including isolated nucleic acids that encode at least one such anti-IL-6 antibody, vectors, host cells, transgenic animals or plants, and methods of making and using thereof, including therapeutic compositions, methods and devices.
    Type: Application
    Filed: September 23, 2011
    Publication date: January 12, 2012
    Applicant: FEMTA PHARMACEUTICALS, INC.
    Inventors: Gerhard Frey, Hwai Wen Chang, Jay Short
  • Humanized anti-IL-6 antibodies
    Patent number: 8062866
    Abstract: The present invention relates to novel chimeric, humanized or CDR-grafted anti-IL-6 antibodies, including isolated nucleic acids that encode at least one such anti-IL-6 antibody, vectors, host cells, transgenic animals or plants, and methods of making and using thereof, including therapeutic compositions, methods and devices.
    Type: Grant
    Filed: November 13, 2009
    Date of Patent: November 22, 2011
    Assignee: Femta Pharmaceuticals, Inc.
    Inventors: Gerhard Frey, Hwai Wen Chang, Jay Short